“I have received calls from many constituents who are desperately trying to find monoclonal antibody treatment, with no luck. The Governor has announced that there is a shortage of supply because the Biden Administration has been keeping the state of Florida from ordering directly from the manufacturer,” Congressman Gus Bilirakis said.
The letter which, included Senators Marco Rubio and Rick Scott, claimed that federal allocation of monoclonal antibody treatments was insufficient and that the government was making it more difficult for Florida to purchase necessary treatments.
“Now, HHS’ decision to control the allocation and amount of mAbs a state or healthcare provider can receive, plus prohibiting these entities from ordering treatments directly from drug manufacturers, remains a serious concern,” the legislators wrote. “This type of volatility and heavy-handed approach is handicapping states who seek to be flexible and innovative to meet the needs of its patients, such as Florida has done.”